PRESS RELEASE published on 09/26/2024 at 10:05, 1 year 2 months ago Semperit: Manfred Stanek appointed new CEO Semperit AG Holding appoints Manfred Stanek as the new CEO, bringing in a seasoned manager to lead the company towards further growth and innovation Market Position CEO Appointment Supervisory Board Semperit Manfred Stanek
PRESS RELEASE published on 09/26/2024 at 10:02, 1 year 2 months ago EQS-Adhoc: Semperit AG Holding: Manfred Stanek appointed new CEO Semperit AG Holding appoints Manfred Stanek as new CEO, succeeding Karl Haider. Stanek to join Executive Board on 1 March 2025 and assume CEO role on 1 April 2025 CEO Appointment Executive Board Semperit AG Holding Karl Haider Manfred Stanek
BRIEF published on 08/13/2024 at 07:35, 1 year 3 months ago Semperit Increases Profitability in the First Half of 2024 Profitability Free Cash Flow Cost-cutting EBITDA Growth Financial Stability
PRESS RELEASE published on 08/13/2024 at 07:30, 1 year 3 months ago Semperit increases profitability in the first half of 2024 Semperit increases profitability in the first half of 2024, with EBITDA up 8% to EUR 47.3 million, and medium-term targets set until 2026 for further growth Financial Results EBITDA Profitability Growth Targets Semperit
BRIEF published on 07/01/2024 at 08:05, 1 year 5 months ago Semperit Finalizes Sale of Remaining Medical Business Growth Strategy Semperit Medical Business Sale Harps Global Industrial Elastomer
PRESS RELEASE published on 07/01/2024 at 08:00, 1 year 5 months ago Semperit finalizes sale of the remaining medical business Semperit AG Holding successfully finalizes the sale of its remaining medical business, including surgical gloves production and packaging, to Harps Global, exiting the glove business completely Sale Semperit AG Holding Harps Global Medical Business Surgical Gloves
BRIEF published on 06/10/2024 at 11:25, 1 year 5 months ago Semperit: Executive Board Chairman Karl Haider Will Not Extend His Contract Executive Board Supervisory Board Contract Semperit Karl Haider
BRIEF published on 06/10/2024 at 11:23, 1 year 5 months ago Semperit AG Holding: Executive Board Chairman Karl Haider Will Not Extend His Contract Executive Board Contract Semperit AG Holding Karl Haider
PRESS RELEASE published on 06/10/2024 at 11:20, 1 year 5 months ago Semperit: Executive Board Chairman Karl Haider will not extend his contract Semperit AG Holding's Executive Board Chairman Karl Haider will not extend his contract, citing personal reasons. Succession planning underway Succession Planning Semperit AG Holding Karl Haider Executive Board Chairman Semperit Group
PRESS RELEASE published on 06/10/2024 at 11:18, 1 year 5 months ago EQS-Adhoc: Semperit AG Holding: Executive Board Chairman Karl Haider will not extend his contract Semperit AG Holding's Executive Board Chairman Karl Haider announces he will not extend his contract, focusing on non-executive tasks. Search for successor to begin Contract Extension Semperit AG Holding Karl Haider Executive Board Chairman Successor Search
Published on 12/05/2025 at 02:35, 5 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 2 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 32 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 37 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 14 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 18 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago Declaration of voting rights at the end of November 2025
